Skip to market wire
InvestLog
← Back to Stock Events← 返回个股快讯
TEVASEC Material DisclosureSEC 重大披露SEC sourceSEC 来源Source link原始来源by InvestLog AIInvestLog AI 整理
Event time: 事件时间：
Published: 文章发布：

TEVA PHARMACEUTICAL INDUSTRIES LTD details a $4.90B ADS offering in 424B5 prospectus梯瓦制药公司 (TEVA) 提交 424B5 招股文件，拟发行 $4.90B 的美国存托股

TEVA PHARMACEUTICAL INDUSTRIES LTD details a $4.90B ADS offering in 424B5 prospectus. The SEC accepted the filing at 2026-09-11T17:05:27-04:00.

Source: SEC filing

梯瓦制药公司 (TEVA) 提交 424B5 招股文件，拟发行 $4.90B 的美国存托股。SEC 接收时间为 2026-09-11T17:05:27-04:00。

来源：SEC 原始文件

View TEVA stock details ->查看 TEVA 个股详情 ->

For information only. Not investment advice.内容仅供参考，不构成投资建议。

Related articles相关阅读

Mignone Roberto sells $14.4M of TEVAMignone Roberto 内部减持 梯瓦制药公司 (TEVA) $14.4M

Insider Sale · September 22, 2026内部人减持 · 2026/9/22

TEVA financing pricing: Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior NotesTeva Pharmaceutical Industries Limited（TEVA）完成融资定价，规模 $4.9B

Material Company Event · September 10, 2026公司公告 · 2026/9/10

Leerink initiates coverage of TEVA with OutperformLeerink 首次覆盖 梯瓦制药公司 (TEVA)，初始评级 跑赢大市（Outperform）

Rating Change · September 9, 2026评级变动 · 2026/9/9